MEF2C Transcription Factor Controls Chondrocyte Hypertrophy and Bone Development
Top Cited Papers
- 1 March 2007
- journal article
- Published by Elsevier in Developmental Cell
- Vol. 12 (3) , 377-389
- https://doi.org/10.1016/j.devcel.2007.02.004
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2Genes & Development, 2005
- Histone Deacetylase 4 Controls Chondrocyte Hypertrophy during SkeletogenesisCell, 2004
- A highly conserved enhancer in mammalian type X collagen genes drives high levels of tissue-specific expression in hypertrophic cartilage in vitro and in vivoMatrix Biology, 2004
- Developmental regulation of the growth plateNature, 2003
- The genetic basis for skeletal diseasesNature, 2003
- Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factorNature Medicine, 2002
- Bone DevelopmentAnnual Review of Cell and Developmental Biology, 2000
- HDAC4 deacetylase associates with and represses the MEF2 transcription factorThe EMBO Journal, 1999
- TRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINSAnnual Review of Cell and Developmental Biology, 1998
- Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red STeratology, 1980